lamivudine
lamivudine is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including EPIVIR, LAMIVUDINE, lamivudine. Available dosage forms: tablet, film coated, powder, solution.
Drug Details
- Generic Name
- lamivudine
- Brand Names
- EPIVIR, LAMIVUDINE, lamivudine
- Application Number
- NDA020564
- Sponsor
- ViiV Healthcare Company
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, POWDER, SOLUTION
- Routes
- ORAL
- Active Ingredients
- LAMIVUDINE
Indications and Usage
1 INDICATIONS AND USAGE Lamivudine oral solution is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. Lamivudine oral solution is a nucleoside analogue reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. (1)